Novo Nordisk shares fell as much as 7% after the company said it aims to launch more than five drugs with multi-blockbuster potential by 2030 and generate over 150 billion Danish kroner in pipeline sales by 2035.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
